AKT inhibitor VIII (Standard)

Overview

AKT inhibitor VIII (Standard) is the analytical standard of AKT inhibitor VIII ( HY-10355 ). This product is intended for research and analytical applications. AKT inhibitor VIII (AKTi-1/2) is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1 , Akt2 , and Akt3 activity with IC 50 s of 58 nM, 210 nM, and 2119 nM, respectively.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Akt | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-10355R
• CAS No.: 612847-09-3
• Molecular Formula: C34H29N7O
• Molecular Weight: 551.64
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source